Osteoporosis Supplement

Article

Millions of US women are affected by the systemic skeletal disorder osteoporosis. As the population of aging female patients continues to rise, so do the medical and economic burdens of osteoporotic fracture. Thus, the time has arrived for both aggressive management and enhanced prevention of this disease in women of all ages.

TO OUR READERS...

Millions of US women are affected by the systemic skeletal disorder osteoporosis. As the population of aging female patients continues to rise, so do the medical and economic burdens of osteoporotic fracture. Thus, the time has arrived for both aggressive management and enhanced prevention of this disease in women of all ages.

Early detection of bone breakdown is an important element of effective osteoporosis intervention. Although bone mineral density (BMD) has long been used as a marker for disease progression, alterations in the microarchitecture of bone equal or exceed BMD in importance. This distinction is necessary in measuring the effectiveness of antiosteoporotic interventions, as even seemingly minor increases in BMD have a significant impact on fracture risk. A thorough understanding of the available treatment options, including their mechanisms of action, usefulness in various patient populations, and compliance rates, is also critical to the success of osteoporosis management.

The body of research supporting osteoporosis risk factors and prevention is growing every year, indicating that patients should be educated on bone maintenance from an early age. Good nutrition and various other lifestyle habits are indeed advantageous for bone, and women can use them to help maintain skeletal integrity and help counteract nonmodifiable risk factors (eg, ethnicity, family history).

We at THE FEMALE PATIENT® welcome you to this special edition, the third in a series focusing on innovations in osteoporosis. We hope that you find its contents enlightening and useful in the everyday practice of female health care.

Articles:

  • Risk Factors for Osteoporosis in Reproductive-Age Women, Chaim Putterman, MD
  • Women at Risk: The Premenopausal Years, Abby Goulder Abelson, MDCounseling premenopausal patients on lifestyle habits to promote bone health, as well as identifying nonmodifiable risk factors, can help prevent the devastating consequences of osteoporosis later in life.
  • Pharmacotherapeutic Options, Charles H. Chesnut III, MDHere the author discusses currently available detection and treatment methods, delineating the distinction between bone quantity and bone quality.
  • CME Test(in PDF format)
Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit: uvahealth.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.